chiang rai city

Chiang Rai City Launches Holistic Care Program to Transform Elderly Quality of Life

CHIANG RAI – Chiang Rai Municipality has launched a comprehensive “Holistic Elderly Care” initiative to support its growing senior population. Led by Mayor Wanchai Chongsuttanamanee, the program focuses on physical, mental, social, and spiritual well-being. Local officials aim to empower seniors with practical knowledge so they can maintain their health and independence at home.

On July 15, 2026, Deputy Mayor Phat Rangseekulphiphat officially opened the latest training session for the project. Key community leaders attended the event, including social welfare expert Nontapat Thapatiwong and acting medical director Porntip Jantrakool.

The initiative reflects a growing push across Thailand to address the needs of an aging society through targeted municipal action. More details on local health initiatives can be found on the Chiang Rai Municipality Official Website.

Key Takeaways

  • Comprehensive Health Focus: The project targets four main pillars of senior health: physical fitness, mental wellness, social connection, and spiritual strength.
  • Practical Skills Workshops: Seniors from seven local communities participated in hands-on training, learning about safe medication use, fall prevention, and memory exercises.
  • Proactive Municipal Leadership: Led by Mayor Wanchai Chongsuttanamanee, the initiative aims to build long-term independence and dignity for Chiang Rai’s elderly residents.

Chiang Rai City Launches Holistic Care Program to Transform Elderly Quality of Life

Empowering Seniors Through Practical Learning

The recent session welcomed Zone 3, Generation 3 participants from seven neighborhoods, including Sri Koed, San Kok Chang, and Sri Sai Moon. Pharmacist Akarawit Phakamsrasri and registered nurse Cheewarat Srijanpliew led the educational seminars. Experts focused heavily on safe medication practices, proper senior nutrition, and effective dementia prevention strategies.

Medical professionals stressed the importance of mental health tracking to prevent isolation and depression among older residents. According to public health data, early intervention significantly improves the daily quality of life for aging individuals. You can track national elderly care frameworks via the Thailand Ministry of Public Health.

Chiang Rai City Launches Holistic Care Program to Transform Elderly Quality of Life

Interactive Workshops and Dementia Prevention

Beyond lectures, the event featured interactive learning stations designed to give seniors immediate, actionable skills. Participants used mobile applications to evaluate their own mental health and engaged in therapeutic art sessions. Another popular station taught seniors how to use traditional Thai herbs to improve oral hygiene safely.

Physical safety remained a major priority, featuring a specialized workshop titled “Safe Aging: No Falls, No Forgetting.” Seniors practiced muscle stretching using traditional Pha Khao Ma loincloths to improve balance and flexibility.

They also trained with a “9-Square Grid” system, a cognitive exercise proven to boost brain function and ward off memory loss. Through these diverse activities, Chiang Rai Municipality continues to build a supportive environment where seniors can age with dignity.

Trending News:

Chiang Rai City Inspects Nightlife Venues to Assure Public Safety

Border Patrol Police Seize 200,000 Speed Pills After Dramatic Car Chase in Phayao

 

Similar Posts

  • Thailand’s DDC Warns of Deadly Bacterial Infections During Rainy Season

    CHIANG RAI – The Department of Disease Control recently issued an urgent public health warning regarding rising bacterial infections. Since January 2026, leptospirosis and melioidosis have killed over 100 people. This matters because vulnerable populations, particularly farmers, must adopt immediate protective measures to prevent further fatal outbreaks. Thailand’s Department of Disease Control (DDC) is sounding […]

  • Youth Phone Addiction in Thailand is Fueling A Mental Health Crisis

    BANGKOK – In Thailand, schools and families are currently battling over who must regulate youth mobile device usage. With data showing that nearly half of young adults gamble online and 33 percent suffer from gaming addiction, excessive screen time is severely harming academic performance and triggering social isolation nationwide. A growing mental health crisis among children […]

  • | | |

    Pakistan faces critical shortage of warehouse faci…

    Pakistan’s healthcare system is facing a significant logistical challenge, as the country lacks a dedicated warehouse to store emergency medicines and medical kits supplied for disease outbreaks and public health emergencies, according to sources within the Ministry of National Health Services. The revelation has raised concerns about the country’s preparedness to manage essential medical supplies, particularly those intended for large-scale disease prevention and treatment programs. Health Ministry sources disclosed that Pakistan does not even have a designated warehouse for storing medicines purchased under the country’s Hepatitis C elimination initiative. The absence of proper storage facilities has forced health authorities to rely on temporary arrangements that fall short of standard warehousing requirements. According to officials, the District Health Office (DHO) in Islamabad has converted parking areas into makeshift storage rooms to accommodate the growing stockpile of medicines and medical supplies. Temporary structures and storage racks have been installed to protect the supplies until a permanent solution becomes available. While the emergency arrangement has helped address immediate storage needs, officials acknowledge that it is not a long-term replacement for a purpose-built medical warehouse designed to safely store pharmaceutical products and emergency health equipment. The shortage of storage space has become even more pressing following the arrival of hundreds of medical kits donated by the United Nations Population Fund (UNFPA). Ministry sources said the UN agency recently supplied 742 Emergency Obstetric and Newborn Care (EmONC) and Family Planning kits to support Pakistan’s maternal and reproductive healthcare services. However, authorities are struggling to find adequate space to safely store the newly received supplies, creating additional logistical challenges for the health sector. Officials also revealed that medicines for approximately 1.6 million patients have already been procured under the Prime Minister’s Hepatitis C Elimination Programme. The large-scale procurement is intended to strengthen Pakistan’s campaign against one of the country’s most widespread infectious diseases, but the lack of dedicated storage infrastructure threatens to complicate distribution and inventory management. Health Ministry sources explained that temporary storage rooms were established in 2023, when additional racks and shelving units were installed to accommodate the increasing volume of medicines. These facilities were developed as an interim solution until permanent warehouse infrastructure could be built. Despite these efforts, experts believe that the growing number of medical supplies and emergency response materials requires modern storage facilities equipped with appropriate environmental controls, inventory management systems, and security measures to ensure the quality and effectiveness of medicines. Responding to concerns, Islamabad District Health Officer Dr. Rashida said that the medicines currently being stored in the temporary facilities are not deteriorating or losing their effectiveness. She maintained that health officials are taking the necessary precautions to preserve the supplies under existing conditions. At the same time, Dr. Rashida acknowledged the urgent need for a dedicated warehouse and confirmed that letters have been sent to development partners requesting support for the establishment of proper storage infrastructure. The shortage highlights broader challenges within Pakistan’s public healthcare system, where expanding disease-control programmes and increasing international assistance have outpaced the development of essential logistics and storage capacity. Health officials hope that with support from development partners and international organizations, permanent warehouse facilities can be established to strengthen the country’s ability to respond to public health emergencies and ensure the safe storage and timely distribution of life-saving medicines and medical supplies.

  • | |

    UK approves new drug aficamten for thousands of patients

    A major breakthrough has been announced in the United Kingdom for thousands of people living with obstructive hypertrophic cardiomyopathy (HCM), a serious heart condition that can significantly affect quality of life. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have simultaneously approved and recommended a new treatment, Aficamten, marketed under the brand name MYQORZO. The decision marks an important milestone in the treatment of obstructive HCM and is expected to benefit around 6,600 patients in England. The coordinated approval process between MHRA and NICE enabled the medicine to become available more quickly than usual, ensuring that eligible patients gain faster access to this innovative therapy. Aficamten is a once-daily oral tablet designed to treat obstructive hypertrophic cardiomyopathy by reducing the excessive contraction of the heart muscle. In people with HCM, the heart muscle becomes abnormally thick, making it harder for the heart to pump blood effectively. This can lead to symptoms such as shortness of breath, chest pain, fatigue, dizziness, fainting, and irregular heart rhythms. By limiting the heart muscle’s excessive contraction, Aficamten improves blood flow from the heart, enhances overall cardiac function, and helps relieve these debilitating symptoms. Clinical trials have shown that Aficamten significantly improves patients’ ability to perform physical activities and reduces many of the common symptoms associated with the disease. Participants experienced better exercise capacity and reported less breathlessness, fatigue, chest discomfort, dizziness, and episodes of abnormal heartbeat. These findings indicate that the medication can substantially improve the quality of life for patients living with obstructive HCM. According to medical experts, the effectiveness of Aficamten is comparable to Mavacamten, another approved treatment for the condition. However, one potential advantage of Aficamten is that patients may require fewer echocardiograms, or heart ultrasound scans, during treatment. This could reduce the need for frequent hospital visits and ongoing monitoring, making treatment more convenient for both patients and healthcare providers. NICE stated that Aficamten was recommended after a comprehensive cost-effectiveness assessment showed that it represents good value for the National Health Service (NHS). The organization also highlighted that close collaboration with the MHRA helped accelerate the review and approval process without compromising safety or effectiveness. Helen Knight, Director of Medicines Evaluation at NICE, described the approval as an important advancement in the treatment of this complex heart disease. She said the new medicine offers fresh hope to patients and expands the range of available treatment options. Julian Beach, Executive Director at the MHRA, said the joint effort between the two organizations demonstrates the importance of collaboration in ensuring that safe and effective medicines reach patients as quickly as possible. The decision has also been welcomed by Cardiomyopathy UK. Chief Executive Katharine McIntosh said the availability of Aficamten would provide patients with more effective treatment options and help improve their overall quality of life. According to NHS England, the new medicine will be available to eligible patients within 30 days of NICE issuing its final guidance. The pharmaceutical company has also agreed to provide the medicine to the NHS at a discounted price, making the treatment more affordable and accessible. The approval represents a significant step forward in the management of obstructive hypertrophic cardiomyopathy and offers renewed hope for thousands of patients across England.

  • | |

    Takhian Tia Mayor Joins Elderly Club Activities, Opens Health Promotion Project and Dharma Initiative

    TAKHIAN TIA, Thailand – On July 24th, 2026, Mr. Mitchai Prakoptham, Mayor of Takhian Tia Subdistrict Municipality, presided over the opening of the Elderly Health Promotion Project for fiscal year 2026. He also participated in the monthly activities of the Takhian Tia Subdistrict Elderly Club and extended birthday wishes to members born in July. This […]

  • |

    Pattaya Mayor Outlines Disease Surveillance Policy and Motivates Disease Response Team at Workshop

    PATTAYA, Thailand – On July 24th, 2026 at 10:00 a.m., Pattaya City Mayor Poramese Ngamphichet chaired a policy briefing for motivating members of the city’s Surveillance and Rapid Response Team (SRRT) in their work on disease surveillance, prevention and control. The session formed part of a practical workshop for knowledge exchange on preventing and controlling […]

Leave a Reply

Your email address will not be published. Required fields are marked *